KEGG   DRUG: Abacavir, lamivudine and zidovudine
Entry
D10838            Mixture   Drug                                   
Name
Abacavir, lamivudine and zidovudine;
Trizivir (TN)
Product
TRIZIVIR (ViiV Healthcare Company)
  Generic
ABACAVIR, LAMIVUDINE AND ZIDOVUDINE (Lupin Pharmaceuticals)
Component
(Abacavir sulfate [DR:D00891] | Abacavir [DR:D07057] | Abacavir succinate [DR:D02734]), Lamivudine [DR:D00353], Zidovudine [DR:D00413]
Class
Antiviral
 DG03107  Anti-HIV agent
Remark
ATC code: J05AR04
Product: D10838<US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
HIV-1 reverse transcriptase [KO:K24802]
  Pathway
ko03230  Viral genome structure
ko03240  Viral replication
ko03250  Viral life cycle - HIV-1
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR04 Zidovudine, lamivudine and abacavir
      D10838  Abacavir, lamivudine and zidovudine <US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Abacavir Sulfate/ Lamivudine/ Zidovudine
    D10838  Abacavir, lamivudine and zidovudine
Drug groups [BR:br08330]
 Antiviral
  DG03107  Anti-HIV agent
   D10838  Abacavir, lamivudine and zidovudine
Drug classes [BR:br08332]
 Antiviral
  DG03107  Anti-HIV agent
   D10838  Abacavir, lamivudine and zidovudine
Antimicrobials [BR:br08307]
 Antivirals
  Genome replication inhibitor
   HIV reverse transcriptase inhibitor
    D10838  Abacavir, lamivudine and zidovudine <US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10838
Other DBs
PubChem: 319902638
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system